Literature DB >> 25954140

An Update on Pulmonary Arterial Hypertension.

Joanna Wapner1, Lea Ann Matura2.   

Abstract

Pulmonary arterial hypertension (PAH) is a progressive disease that ultimately leads to right heart failure and death. PAH is defined as a mean pulmonary arterial pressure ≥ 25 mm Hg with a pulmonary capillary wedge pressure ≤ 15 mm Hg at rest. The diagnosis of PAH is one of exclusion; diagnostics include an extensive history, serology, chest radiograph, pulmonary function tests, ventilation/perfusion scan, transthoracic echocardiogram, and right heart catheterization. Treatment and care of patients with PAH can be complex. Therefore, the nurse practitioner is an integral member of the healthcare team caring for PAH patients, helping to ensure seamless care and support.

Entities:  

Keywords:  diagnosis; pathophysiology; pulmonary arterial hypertension; treatment

Year:  2015        PMID: 25954140      PMCID: PMC4418237          DOI: 10.1016/j.nurpra.2015.02.004

Source DB:  PubMed          Journal:  J Nurse Pract        ISSN: 1555-4155            Impact factor:   0.767


  26 in total

Review 1.  Calcium-channel blockers in pulmonary arterial hypertension.

Authors:  Marie-Camille Chaumais; Elise Artaud Macari; Olivier Sitbon
Journal:  Handb Exp Pharmacol       Date:  2013

2.  Sildenafil citrate therapy for pulmonary arterial hypertension.

Authors:  Nazzareno Galiè; Hossein A Ghofrani; Adam Torbicki; Robyn J Barst; Lewis J Rubin; David Badesch; Thomas Fleming; Tamiza Parpia; Gary Burgess; Angelo Branzi; Friedrich Grimminger; Marcin Kurzyna; Gérald Simonneau
Journal:  N Engl J Med       Date:  2005-11-17       Impact factor: 91.245

Review 3.  Oral anticoagulation for pulmonary arterial hypertension: systematic review and meta-analysis.

Authors:  Daniel Caldeira; Maria José Loureiro; João Costa; Fausto J Pinto; Joaquim J Ferreira
Journal:  Can J Cardiol       Date:  2014-04-25       Impact factor: 5.223

4.  Predicting survival in pulmonary arterial hypertension: insights from the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL).

Authors:  Raymond L Benza; Dave P Miller; Mardi Gomberg-Maitland; Robert P Frantz; Aimee J Foreman; Christopher S Coffey; Adaani Frost; Robyn J Barst; David B Badesch; C Gregory Elliott; Theodore G Liou; Michael D McGoon
Journal:  Circulation       Date:  2010-06-28       Impact factor: 29.690

5.  Hypoxic vasoconstriction in intact lungs: a role for NADPH oxidase-derived H(2)O(2)?

Authors:  N Weissmann; A Tadic; J Hänze; F Rose; S Winterhalder; M Nollen; R T Schermuly; H A Ghofrani; W Seeger; F Grimminger
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2000-10       Impact factor: 5.464

6.  Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT).

Authors:  Nazzareno Galiè; Marius M Hoeper; Marc Humbert; Adam Torbicki; Jean-Luc Vachiery; Joan Albert Barbera; Maurice Beghetti; Paul Corris; Sean Gaine; J Simon Gibbs; Miguel Angel Gomez-Sanchez; Guillaume Jondeau; Walter Klepetko; Christian Opitz; Andrew Peacock; Lewis Rubin; Michael Zellweger; Gerald Simonneau
Journal:  Eur Heart J       Date:  2009-08-27       Impact factor: 29.983

Review 7.  Challenges in the diagnosis and treatment of pulmonary arterial hypertension.

Authors:  Jean-Luc Vachiéry; Sean Gaine
Journal:  Eur Respir Rev       Date:  2012-12-01

8.  Managing pulmonary arterial hypertension and optimizing treatment options: prognosis of pulmonary artery hypertension.

Authors:  Vallerie McLaughlin
Journal:  Am J Cardiol       Date:  2013-04-16       Impact factor: 2.778

9.  Cluster analysis of symptoms in pulmonary arterial hypertension: a pilot study.

Authors:  Lea Ann Matura; Annette McDonough; Diane L Carroll
Journal:  Eur J Cardiovasc Nurs       Date:  2012-01-11       Impact factor: 3.908

Review 10.  Relevant issues in the pathology and pathobiology of pulmonary hypertension.

Authors:  Rubin M Tuder; Stephen L Archer; Peter Dorfmüller; Serpil C Erzurum; Christophe Guignabert; Evangelos Michelakis; Marlene Rabinovitch; Ralph Schermuly; Kurt R Stenmark; Nicholas W Morrell
Journal:  J Am Coll Cardiol       Date:  2013-12-24       Impact factor: 24.094

View more
  3 in total

1.  Outcomes of Pulmonary Arterial Hypertension Are Improved in a Specialty Care Center.

Authors:  Hongyang Pi; Chad M Kosanovich; Adam Handen; Michael Tao; Jacqueline Visina; Gabrielle Vanspeybroeck; Marc A Simon; Michael G Risbano; Aken Desai; Michael A Mathier; Belinda N Rivera-Lebron; Quyen Nguyen; Jennifer Kliner; Mehdi Nouraie; Stephen Y Chan
Journal:  Chest       Date:  2020-02-25       Impact factor: 9.410

Review 2.  Are statins beneficial for the treatment of pulmonary hypertension?

Authors:  Lei Wang; Ting Yang; Chen Wang
Journal:  Chronic Dis Transl Med       Date:  2017-12-11

3.  Elicitation of health state utilities associated with the mode of administration of drugs acting on the prostacyclin pathway in pulmonary arterial hypertension.

Authors:  Evan W Davies; Samuel Llewellyn; Amélie Beaudet; Charlotte E Kosmas; Wendy Gin-Sing; Helen A Doll
Journal:  Patient Prefer Adherence       Date:  2018-06-21       Impact factor: 2.711

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.